What is CVE-2017-18228?

CVE-2017-18228 is a medium-severity vulnerability in Bmc Remedy_action_request_system, classified under Cross-site Scripting. CVSS score: 5.4/10. Published 2018-03-12.

How severe is CVE-2017-18228?

Medium severity. CVSS v3 base score is 5.4 out of 10.

XSS in Bmc Remedy_action_request_system

CVE-2017-18228

Remedy Mid Tier in BMC Remedy AR System 9.1 allows XSS via the ATTKey parameter in an arsys/servlet/AttachServlet request.

Vulnerability class: XSS (Cross-Site Scripting)

EPSS: 0.005 (40.2th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 5.4 (Medium). Vector: CVSS:3.0/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N.

Affected products

Bmc Remedy_action_request_system
N/a — versions n/a

Weakness classification (CWE)

CWE-79 — Cross-site Scripting

References

cve@mitre.org (x_refsource_MISC, Vendor Advisory)

Frequently asked questions

What is CVE-2017-18228?: CVE-2017-18228 is a medium-severity vulnerability in Bmc Remedy_action_request_system, classified under Cross-site Scripting. CVSS score: 5.4/10. Published 2018-03-12.
How severe is CVE-2017-18228?: Medium severity. CVSS v3 base score is 5.4 out of 10.